Each vial contains 1 mg of IGF-1 LR3, in lyophilized form.
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a synthetic 83-amino-acid analogue of human IGF-1, modified by an arginine substitution at position 3 and a 13-amino-acid N-terminal extension. These changes markedly reduce binding to IGF binding proteins, extending its available half-life relative to native IGF-1.
Published research uses IGF-1 LR3 in cell culture as a potent activator of the IGF-1 receptor and downstream PI3K/Akt and MAPK signalling, and it is a common component of serum-free media formulations. Animal-model work reports endpoints in protein synthesis, cell proliferation and differentiation.
Areas of published research
- IGF-1 receptor activation and downstream PI3K/Akt and MAPK signalling in cell culture
- Protein synthesis rate and myotube diameter in C2C12 and primary muscle cell preparations
- Satellite cell proliferation and differentiation endpoints
- Use as a potent, binding-protein-resistant supplement in serum-free media formulations
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.


Reviews
There are no reviews yet.